Annual Shareholders Equity
$114.42 M
-$53.11 M-31.70%
December 31, 2023
Summary
- As of February 7, 2025, NXTC annual stockholders equity is $114.42 million, with the most recent change of -$53.11 million (-31.70%) on December 31, 2023.
- During the last 3 years, NXTC annual shareholders equity has fallen by -$179.30 million (-61.04%).
- NXTC annual shareholders equity is now -64.41% below its all-time high of $321.48 million, reached on December 31, 2019.
Performance
NXTC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$75.59 M
-$9.85 M-11.53%
September 30, 2024
Summary
- As of February 7, 2025, NXTC quarterly stockholders equity is $75.59 million, with the most recent change of -$9.85 million (-11.53%) on September 30, 2024.
- Over the past year, NXTC quarterly shareholders equity has dropped by -$38.83 million (-33.94%).
- NXTC quarterly shareholders equity is now -77.21% below its all-time high of $331.76 million, reached on March 31, 2020.
Performance
NXTC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NXTC Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.7% | -33.9% |
3 y3 years | -61.0% | -69.5% |
5 y5 years | +343.7% | -55.7% |
NXTC Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -51.0% | at low | -67.6% | at low |
5 y | 5-year | -64.4% | at low | -77.2% | at low |
alltime | all time | -64.4% | +343.7% | -77.2% | +243.4% |
NextCure Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $75.59 M(-11.5%) |
Jun 2024 | - | $85.44 M(-13.7%) |
Mar 2024 | - | $99.05 M(-13.4%) |
Dec 2023 | $114.42 M(-31.7%) | $114.42 M(-9.5%) |
Sep 2023 | - | $126.45 M(-8.7%) |
Jun 2023 | - | $138.43 M(-10.2%) |
Mar 2023 | - | $154.20 M(-8.0%) |
Dec 2022 | $167.53 M(-28.2%) | $167.53 M(-7.7%) |
Sep 2022 | - | $181.54 M(-8.4%) |
Jun 2022 | - | $198.20 M(-7.4%) |
Mar 2022 | - | $213.94 M(-8.3%) |
Dec 2021 | $233.39 M | $233.39 M(-6.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $248.23 M(-5.8%) |
Jun 2021 | - | $263.60 M(-5.6%) |
Mar 2021 | - | $279.16 M(-5.0%) |
Dec 2020 | $293.72 M(-8.6%) | $293.72 M(-4.4%) |
Sep 2020 | - | $307.34 M(-4.5%) |
Jun 2020 | - | $321.92 M(-3.0%) |
Mar 2020 | - | $331.76 M(+3.2%) |
Dec 2019 | $321.48 M(-784.8%) | $321.48 M(+88.4%) |
Sep 2019 | - | $170.65 M(-4.4%) |
Jun 2019 | - | $178.59 M(-438.8%) |
Mar 2019 | - | -$52.71 M(+12.3%) |
Dec 2018 | -$46.94 M(+92.3%) | -$46.94 M |
Dec 2017 | -$24.41 M | - |
FAQ
- What is NextCure annual stockholders equity?
- What is the all time high annual shareholders equity for NextCure?
- What is NextCure annual shareholders equity year-on-year change?
- What is NextCure quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NextCure?
- What is NextCure quarterly shareholders equity year-on-year change?
What is NextCure annual stockholders equity?
The current annual shareholders equity of NXTC is $114.42 M
What is the all time high annual shareholders equity for NextCure?
NextCure all-time high annual stockholders equity is $321.48 M
What is NextCure annual shareholders equity year-on-year change?
Over the past year, NXTC annual stockholders equity has changed by -$53.11 M (-31.70%)
What is NextCure quarterly stockholders equity?
The current quarterly shareholders equity of NXTC is $75.59 M
What is the all time high quarterly shareholders equity for NextCure?
NextCure all-time high quarterly stockholders equity is $331.76 M
What is NextCure quarterly shareholders equity year-on-year change?
Over the past year, NXTC quarterly stockholders equity has changed by -$38.83 M (-33.94%)